Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma ; volume:91 ; number:4 ; day:24 ; month:3 ; year:2023 ; pages:337-344 ; date:4.2023
Cancer chemotherapy and pharmacology ; 91, Heft 4 (24.3.2023), 337-344, 4.2023
- Urheber
-
Legros, Laurence
Pascale, Alina
Guettier, Catherine
Eftekhari, Pirayeh
Merabet, Yasmina Ben
Stang, Maryse
Bossevot, Rachel
Goldschmidt, Emma
Ulusakarya, Ayhan
Morisset, Stephane
Lewin, Maïté
Samuel, Didier
Rosmorduc, Olivier
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00280-023-04519-6
- URN
-
urn:nbn:de:101:1-2023081721062931351991
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Legros, Laurence
- Pascale, Alina
- Guettier, Catherine
- Eftekhari, Pirayeh
- Merabet, Yasmina Ben
- Stang, Maryse
- Bossevot, Rachel
- Goldschmidt, Emma
- Ulusakarya, Ayhan
- Morisset, Stephane
- Lewin, Maïté
- Samuel, Didier
- Rosmorduc, Olivier
- SpringerLink (Online service)
Ähnliche Objekte (12)
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy
Sorafenib versus lenvatinib-based sequential systemic therapy for advanced hepatocellular carcinoma: a real-world analysis
Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report
Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma
Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy
Sorafenib versus lenvatinib-based sequential systemic therapy for advanced hepatocellular carcinoma: a real-world analysis
Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report
Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma
Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy
Sorafenib versus lenvatinib-based sequential systemic therapy for advanced hepatocellular carcinoma: a real-world analysis
Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report
Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma